US Ambassador affirms RCSI Medical University of Bahrain's role in advancing Medical and Academic partnerships with US
The Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain welcomed yesterday His Excellency Steven C. Bondy, U.S. Ambassador to Bahrain, and a delegation including Mr Nathanael Lynn, Chief of the Public Affairs Section, Ms Samar Hasan, Education Specialist, and Dr Fathima Nasmy, Physician, at its campus in Busaiteen.
Welcoming the delegation, Professor Sameer Otoom, President of RCSI Medical University of Bahrain, and members of the University's Executive Committee, provided a guided viewing of the University's New Academic Building currently under construction - a significant development set to enhance the student experience.
The meeting commenced with an overview by Mr Stephen Harrison-Mirfield, Managing Director, detailing the University's history, relationship with partner hospitals and strategic direction.
A key focus of the meeting was the University's robust academic and clinical collaborations with leading US universities and hospitals. Mr Fadi Ghosn, Head of Recognition, Careers & Alumni, provided details on student research and clinical electives through such partnerships with prestigious institutions such as Johns Hopkins University, Yale University, the University of Alabama at Birmingham, the University of Tennessee Health Science Centre, Penn State College of Medicine and George Washington University.
As a result of this collaboration, 224 graduates of RCSI Medical University of Bahrain — including 117 American nationals — are now practising in the United States, a testament to the University's rigorous international standards and worldclass training it provides.
During the meeting, the delegation also explored potential federal funding opportunities for American nationals to study at the University, further expanding the collaboration between the University and U.S. institutions and demonstrating a shared commitment to advancing medical education and research.
Steven C. Bondy, stated, 'Its partnerships with leading U.S. universities and hospitals are expanding opportunities for clinical training, research, and student exchange. These efforts deepen the educational ties between the United States and Bahrain while advancing global healthcare.'
Commenting on the visit, Professor Otoom stated, 'RCSI Medical University of Bahrain extends its sincere thanks to His Excellency Steven C. Bondy, U.S. Ambassador to the Kingdom of Bahrain and the delegation for their visit, which highlights the strategic importance of our collaborative partnerships with esteemed U.S. institutions. These partnerships are crucial to our mission of providing students with a world-class medical education, fostering invaluable international exchange in healthcare, and ultimately enhancing the quality of care both regionally and globally.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Tribune
6 days ago
- Daily Tribune
RCSI Bahrain sends nurses to Taiwan for training
Nursing students and faculty from Bahrain may soon gain hands-on training experience in Taiwan, as RCSI Medical University of Bahrain pushes ahead with an international exchange programme under a growing partnership with Taiwan's top nursing institution. Training Abroad The initiative follows a follow-up visit by a senior delegation from RCSI Bahrain to the National Taipei University of Nursing and Health Sciences (NTUNHS) in April. The collaboration builds on a Memorandum of Understanding signed in 2024, and includes student clinical placements, joint research initiatives, and professional development programmes for faculty. Leading the delegation were Professor Kathryn Strachan, Head of the School of Nursing and Midwifery, and Dr Maryam Alaradi, Director of the BSc Nursing Programme. They reviewed NTUNHS's teaching facilities, including its simulation centre, and held discussions with senior Taiwanese academics to finalise the scope of collaboration. Global Exposure 'This visit represents a significant advancement in our strategic engagement with NTUNHS,' said Professor Strachan. 'We are particularly focused on enhancing academic and research exchange programmes that enrich both faculty expertise and student learning as well as exposure to international health systems outside the Middle East.' The delegation praised the quality of Taiwan's nursing education and its emphasis on student-centred learning, which they said closely aligns with RCSI Bahrain's approach. Diplomatic Support RCSI Bahrain also extended appreciation to H.E. Bob L.J. Chen, Representative of the Taipei Trade Office in Bahrain, and Vice Consul Shadin Lu for facilitating the visit. The institution noted that the partnership supports its mission to equip graduates with the clinical skills and cultural awareness to succeed in a globalised healthcare environment. Discussions are expected to continue as the two institutions move to activate student and faculty exchanges in the coming academic year.
Gulf Insider
03-06-2025
- Gulf Insider
COVID Vaccine Removed for Kids, Pregnant Women
On Tuesday, HHS Secretary Robert F. Kennedy Jr. delivered a historic course correction from the Biden-era vaccine alongside NIH Director Dr. Jay Bhattacharya and FDA Commissioner Dr. Marty Makary, Kennedy announced that COVID-19 vaccine recommendations for healthy children and pregnant women were officially removed from the CDC's immunization schedule. 'Hi, everybody. I'm Robert F. Kennedy, Jr., your HHS secretary. And I'm here today with NIH Director Dr. Jay Bhattacharya and FDA Commissioner Dr. Marty Makary. I couldn't be more pleased to announce that, as of today, the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule.' It was an unmistakable shift away from coercive one-size-fits-all medicine, and a clear signal that data, not politics, is now leading the conversation. On Tuesday, HHS Secretary Robert F. Kennedy Jr. delivered a historic course correction from the Biden-era vaccine policy. Standing alongside NIH Director Dr. Jay Bhattacharya and FDA Commissioner Dr. Marty Makary, Kennedy announced that COVID-19 vaccine recommendations for… — The Vigilant Fox 🦊 (@VigilantFox) June 1, 2025 Today, Dr. Marty Makary took the fight straight into the lion's den—appearing on CBS to dismantle the network's go-to vaccine talking points. When host Margaret Brennan tried to paint the updated guidance as confusing, Makary didn't flinch. 'Can you clearly state what the policy is? Because this is confusing,' she asked. Makary responded without hesitation: 'Yeah, we believe the recommendation should be with a patient and their doctor.' That's when the real shift came into focus. 'So we're going to get away from these blanket recommendations in healthy young Americans.' 'On the COVID vaccine schedule, we don't want to see kids kicked out of school because a 12-year-old girl is not getting her fifth COVID booster shot.' 'We don't see the data there to support a young, healthy child getting a repeat infinite annual COVID vaccine.' He then laid out the sheer absurdity of where the old policy was heading. 'There's a theory that we should sort of blindly approve the new COVID boosters in young, healthy kids every year in perpetuity, and a young girl born today should get 80 COVID mRNA shots or other COVID shots in her average lifespan.' 'We're saying that's a theory, and we'd like to check in and get some randomized controlled data. It's been about four years since the original randomized trials. So we'd like an evidence based approach.' And then came the knockout line—delivered with facts no one could deny. 'That is a decision between a parent and their doctor—I don't know if you know these statistics, but 88% of American kids, their parents have said no to the COVID shot last season. So America, the vast majority of Americans are saying no.' Today, Dr. Marty Makary took the fight straight into the lion's den—appearing on CBS to dismantle the network's go-to vaccine talking host Margaret Brennan tried to paint the updated guidance as confusing, Makary didn't flinch.'Can you clearly state what the… — The Vigilant Fox 🦊 (@VigilantFox) June 1, 2025 Brennan tried to shift gears—falling back on CDC data to argue that even healthy kids remained at risk. 'So the CDC data said 41% of children aged 6 months to 17 years hospitalized with COVID between 2022 and 2024 did not have a known underlying condition. In other words, they looked healthy,' she said. 'And COVID was serious for them.' But Makary was ready. Calm and precise, he dismantled the claim with surgical clarity. 'So first of all, we know the CDC data is contaminated with a lot of false positives from incidental positive COVID tests with routine testing of every kid that walks in the hospital.' 'We know that data historically under the Biden administration did not distinguish being sick from COVID or an incidental positive COVID test.' He shared what he's heard from the people who actually run the ICUs in America. 'When you go to an ICU in America and you ask how many people are in the ICU that are healthy, that are sick with COVID? The answer I get again, again is we haven't seen that in a year or years.' That's why, he warned, making universal recommendations based on flawed data isn't just wrong—it's dangerous. 'And so the worst thing you can do in public health is to put out an absolute universal recommendation in young, healthy kids.' 'And the vast majority of Americans are saying, no, we want to see some data. And you say, forget about the data, just get it anyway.' Brennan tried to shift gears—falling back on CDC data to argue that even healthy kids remained at risk.'So the CDC data said 41% of children aged 6 months to 17 years hospitalized with COVID between 2022 and 2024 did not have a known underlying condition. In other words, they… — The Vigilant Fox 🦊 (@VigilantFox) June 1, 2025 But it was the final exchange that landed like a sledgehammer. When Brennan questioned why the HHS bypassed the CDC's Advisory Committee on Immunization Practices (ACIP) for the new policy shift, Makary landed a haymaker. 'That panel has been a kangaroo court where they just rubberstamp EVERY single vaccine put in front of them.' He said the committee hadn't been focused on science, but on messaging and marketing. 'You look at the minutes of the last couple of years, they say, we want a simple message for everybody just so they can understand it. It was not a data based conversation. It was a conversation based on marketing and ease.' And without real evidence, he warned, these recommendations become little more than guesswork. 'If there's zero clinical data, you're opining. I mean—it's a theory.' 'And so we don't want to put out an absolute recommendation for kids, with no clinical data to support it.' The implication was unmistakable: public health decisions should be based on evidence and transparency—not rubber stamps and slogans. For the first time in years, someone on national television was calling out the system. But it was the final exchange that landed like a Brennan questioned why the HHS bypassed the CDC's Advisory Committee on Immunization Practices (ACIP) for the new policy shift, Makary landed a haymaker.'That panel has been a kangaroo court where they just… — The Vigilant Fox 🦊 (@VigilantFox) June 1, 2025 Also read: Moderna Disables Comments On X Post Announcing New Covid Shot Amid Backlash
Biz Bahrain
03-06-2025
- Biz Bahrain
RCSI Medical University of Bahrain Expands Research and Clinical Training Partnerships with Leading Academic and Healthcare Institutions in Thailand
The Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain has taken a significant step in advancing its international outlook by formalising a new partnership with the Faculty of Medicine Ramathibodi Hospital, Mahidol University in Bangkok, Kingdom of Thailand, as part of its ongoing commitment to expanding international academic and clinical collaboration. On May 23rd, a Memorandum of Understanding (MoU) was signed by Professor Sameer Otoom, President of RCSI Medical University of Bahrain, and Clinical Professor Artit Ungkanont, M.D., Dean of the Faculty of Medicine Ramathibodi Hospital. The agreement facilitates our students' participation in clinical and research electives across a broad range of medical specialities at Ramathibodi Hospital and opens the door to future collaboration in academia, exchange and joint initiatives. Professor Ungkanont, commented on the agreement: 'We believe that through this collaboration, both institutions will grow stronger—by learning from each other, sharing resources and supporting one another in the pursuit of global health equity and the development of future healthcare leaders.'This landmark agreement was part of a wider strategic visit to the Kingdom of Thailand, during which the University delegation also held high-level discussions with Associate Professor Dr Taveesin Tanprayoon, Chief Medical Officer, and Ms Artirat Charukitpipat, Chief Executive Officer of Bumrungrad International Hospital in Bangkok. Discussions focused on establishing clinical elective opportunities in cardiology and exploring avenues for collaborative research in key areas such as diabetes, obesity, cardiovascular diseases and genomics. Commenting on the significance of the partnership, Professor Otoom stated: 'The MoU with Ramathibodi Hospital, Mahidol University, and our productive discussion with leading healthcare institutions in Thailand represent an important milestone in our mission to provide world-class clinical and research opportunities for our students. These efforts reflect RCSI Medical University of Bahrain's commitment to academic excellence, global health engagement, and the advancement of medical education through strategic international alliances. These developments follow the recent visit of His Excellency Sumate Chulajata, Ambassador of the Kingdom of Thailand to the Kingdom of Bahrain, to the University campus. During that meeting, held earlier in May, the University outlined its intention to strengthen ties with Thai institutions through formal partnerships and mutual engagement. Further reinforcing this strategic direction, RCSI Medical University of Bahrain participated in the International Diabetes Federation (IDF) World Diabetes Congress 2025 in Thailand in April. A group of faculty and students contributed actively to scientific discussions and presented impactful research findings, highlighting the importance of regular ophthalmologic screening for pre-diabetic patients. Their research revealed that signs of diabetic retinopathy may be evident at HbA1c levels between 5.7% and 6.4%, a lower threshold than previously assumed. As RCSI Medical University of Bahrain continues to strengthen its network of global partners, the University remains focused on enhancing the academic experience and clinical training of its students, while fostering impactful research that addresses global health challenges.
